Indian Hospital Chain Manipal Health Seeks $852M in Stock Market Debut

Manipal Health Enterprises, a major Indian hospital operator backed by Singapore's Temasek, has filed paperwork to go public and raise $852 million. The company plans to use the money to pay off debt and fund its recent $700 million acquisition of rival Sahyadri Hospitals.

A prominent Indian healthcare company backed by Singapore investment firm Temasek has submitted paperwork for a stock market debut, seeking to capitalize on growing demand for specialized medical services across India.

Manipal Health Enterprises announced Tuesday it intends to generate 80 billion rupees (equivalent to $852.24 million) by issuing new shares to investors. The company’s current shareholders also plan to offload 43.2 million existing shares as part of the offering, according to preliminary documents filed with regulators.

The Bengaluru-headquartered healthcare provider is positioning itself to benefit from India’s expanding appetite for advanced medical treatments, which industry experts believe will drive future growth in the nation’s healthcare sector. The medical industry has attracted substantial investment from major global firms including Blackstone, Novo Nordisk, and KKR.

Company officials have not disclosed the complete size of their planned public offering.

Over recent years, Manipal Health has established itself as one of India’s most active healthcare companies in terms of acquisitions and expansion. The firm’s most recent major purchase was Sahyadri Hospitals, which it acquired for $700 million.

The timing of the IPO announcement comes as India’s stock markets face significant challenges, with declining values driven by global economic uncertainty, reduced market liquidity, and ongoing withdrawal of funds by international investors.

According to the regulatory filing, Manipal Health intends to allocate the IPO funds toward paying down existing debt obligations and completing the financing for its Sahyadri Hospitals acquisition.